Stable and unstable angina difference as per harrison and goldberg
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
I now have sufficient information from both Harrison's and Goldman-Cecil to construct a comprehensive comparison. Let me compile this into a well-organized response.
Stable vs Unstable Angina: Harrison's & Goldman-Cecil
1. Definition & Core Concept
| Feature | Stable Angina | Unstable Angina (UA) |
|---|---|---|
| Harrison's | "An episodic clinical syndrome resulting from transient myocardial ischemia" — reproducible, effort-related | Part of the Acute Coronary Syndrome (ACS) spectrum; distinguished from NSTEMI only by the absence of elevated cardiac biomarkers (troponin) |
| Goldman-Cecil | Chronic ischemic heart disease; CCS class I–II; symptoms provoked by exertion | Non-ST elevation ACS where subtotal coronary occlusion causes ischemia without myonecrosis — "if the supply-demand imbalance is transient, myocytes become ischemic but do not die… troponin is absent; a diagnosis of unstable angina is made" |
2. Pathophysiology
Stable Angina
- Harrison's: Fixed atherosclerotic stenosis → demand-supply mismatch triggered by increased oxygen demand (exertion, emotion, tachycardia). Silent ischemia possible; coronary artery calcification (CAC) may be quantified.
- Goldman-Cecil: Most common cause is an obstructed/stenotic coronary artery. Alternative mechanisms include microvascular dysfunction, vasoconstriction at a dynamic stenosis, or mural thrombosis.
Unstable Angina
- Harrison's: Acute plaque rupture/erosion → thrombosis → abrupt flow reduction. The thrombus is typically non-occlusive (partially occlusive). Flow reduction may also be due to dynamic obstruction (vasospasm) or mechanical obstruction.
- Goldman-Cecil: Coronary atherosclerotic plaque rupture → platelet aggregation and thrombus formation → subtotal occlusion. Platelets release TXA2, serotonin, ADP, vWF → platelet plug → thrombin generated → fibrin-rich thrombus. "Distal embolization of platelet-rich thrombi" may also compromise flow. Occasionally, total occlusion with extensive collaterals can still present as UA/NSTEMI rather than STEMI.
3. Clinical Features
| Feature | Stable Angina | Unstable Angina |
|---|---|---|
| Precipitant | Exertion, emotion, cold, meals | Occurs at rest, or with minimal exertion, or is new-onset severe |
| Pattern | Reproducible, predictable | New-onset, crescendo (increasing frequency/severity/duration), or at rest |
| Duration | Typically 2–5 minutes | May be prolonged (>20 min at rest) |
| Relief | Rest or sublingual nitrates | May not fully resolve with nitrates or rest |
| CCS Class (Goldman-Cecil) | Class I–II (exertion-provoked) | Class III–IV (minimal exertion or rest) |
| Levine's sign (Harrison's) | Present (clenched fist over sternum) | Same chest discomfort character |
| Nocturnal / decubitus | Angina decubitus possible | More characteristic of UA |
Harrison's notes that angina in women may differ in description from men, and that radiation to the trapezius suggests pericarditis, not ischemia.
4. Biomarkers
| Stable Angina | Unstable Angina | |
|---|---|---|
| Troponin | Normal (no necrosis) | Normal — this is what distinguishes UA from NSTEMI |
| CK-MB | Normal | Normal |
Harrison's key distinction: Among patients with prolonged ischemic discomfort at rest, circulating cardiac biomarkers (hsTn) separate UA (negative) from NSTEMI (positive). Both are on the NSTE-ACS spectrum.
Goldman-Cecil: "If cardiac biomarkers are not elevated, the patient is diagnosed with unstable angina. If cardiac biomarkers are elevated, the final diagnosis is NSTEMI."
5. ECG Findings
| Stable Angina | Unstable Angina | |
|---|---|---|
| At rest | Usually normal | May show ST depression, T-wave inversion, or transient ST changes |
| During episode | Transient ST depression or T-wave changes | ST depression/T-wave inversion (non-ST elevation) |
| Goldman-Cecil (Fig. 57-1) | — | Partially occluded artery → no ST elevation on ECG → UA (troponin −) or NSTEMI (troponin +) |
6. Coronary Anatomy
| Stable Angina | Unstable Angina | |
|---|---|---|
| Harrison's | Fixed obstructive stenosis; CAC on CT | Disrupted vulnerable plaque (thin fibrous cap, lipid-rich core) with superimposed thrombus |
| Goldman-Cecil | Obstructive stenosis ± microvascular dysfunction | Ruptured/eroded plaque, platelet-rich thrombus, subtotal occlusion; may show multi-site plaque ulceration (systemic inflammatory process) |
7. Prognosis & Risk
Harrison's (Stable Angina):
- Prognosis depends on LV function, extent of CAD, and degree of ischemia on stress testing.
- Risk factors: age >75 years, hypertension, dyslipidemia, diabetes, obesity, peripheral/cerebrovascular disease, prior MI. Elevated CRP and increased carotid intimal thickness also confer higher risk.
Goldman-Cecil (UA/NSTE-ACS):
- GRACE score used for risk stratification (incorporates age, HR, BP, Killip class, ST deviation, cardiac arrest, creatinine, biomarkers).
- CRUSADE score for bleeding risk.
- High-risk patients benefit from invasive strategy (coronary angiography + revascularization): 20–40% reduction in recurrent ischemia/MI, ~10% mortality reduction, ~18-month delay in recurrent MI/death.
8. Management Highlights
Stable Angina (Harrison's)
- Lifestyle modification, risk factor control (HTN, dyslipidemia, diabetes, smoking)
- Anti-anginal drugs: nitrates, β-blockers, calcium channel blockers
- Antiplatelet therapy (aspirin), statins
- Revascularization (PCI or CABG) per extent of disease and symptoms
Unstable Angina (Harrison's & Goldman-Cecil)
- Immediate: Bed rest, continuous ECG monitoring, supplemental O₂ if SpO₂ <90%
- Anti-ischemic: IV/sublingual nitrates, β-blockers (avoid if acute HF or low output), CCBs
- Antiplatelet: Aspirin + P2Y₁₂ inhibitor (clopidogrel, prasugrel, or ticagrelor)
- Anticoagulation: Unfractionated heparin, LMWH (enoxaparin), or fondaparinux; bivalirudin preferred peri-PCI
- GP IIb/IIIa inhibitors: For PCI patients (abciximab, eptifibatide, tirofiban) — initiated at time of angiography, not routinely beforehand
- Invasive strategy: For high-risk patients — coronary angiography ± revascularization
Summary Table
| Parameter | Stable Angina | Unstable Angina |
|---|---|---|
| Onset | Predictable with exertion | Unpredictable, at rest or new/worsening |
| Plaque | Stable, fixed stenosis | Ruptured/eroded vulnerable plaque |
| Thrombus | Absent | Platelet-rich, partially occlusive |
| Troponin | Negative | Negative (if positive → NSTEMI) |
| ST changes | Transient during stress | ST depression/T-wave changes at rest |
| CCS Class | I–II | III–IV |
| Mechanism | Demand > supply (fixed obstruction) | Supply reduced (acute thrombosis) |
| Risk | Chronic, stable | Acute, requires urgent hospitalization |
| Treatment | Medical ± elective revascularization | Urgent antithrombotic + consider early invasive |
Sources:
- Harrison's Principles of Internal Medicine, 22nd ed. (2025) — Chapters 284 (Stable Angina/IHD) & 285 (NSTE-ACS), pp. 2136–2142, 2148+
- Goldman-Cecil Medicine, International Edition — Chapters 39 (Chronic Ischemic Heart Disease) & 57 (Non-ST Elevation ACS), with CCS grading table and ACS flowchart (Fig. 57-1)
This is a shared conversation. Sign in to Orris to start your own chat.